tiprankstipranks
TipRanksTop Financial ExpertsInsidersJohn Henneman

John Henneman Insider Profile

4 Followers
John Henneman, Director at Anika Therapeutics, holds 65.27K shares in Anika Therapeutics (Ticker: ANIK), holds 13.36K shares in Aprea Therapeutics (Ticker: APRE), holds 105.77K shares in Orthofix Medical (Ticker: OFIX).
See the Hottest Stocks Based on Insider Trading >
tipranks
John Henneman

John Henneman
Anika Therapeutics (ANIK)
Director

Ranked #61,108 out of 108,921 Corporate Insiders

Profitable Transactions

55%
6 out of 11 Profitable Transactions

Average Return

-2.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$3M
46.47%
33.62%
19.54%
0.36%
A breakdown of John Henneman's holdings
See the Top Stocks by Insiders

Insider Roles

Anika Therapeutics
(ANIK)
Director
Orthofix Medical
(OFIX)
Director
Integra Lifesciences
(IART)
CorpVP, CAO
Aprea Therapeutics
(APRE)
Director
Roles that John Henneman holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
R1 RCM
(RCM)
Rating:Informative Buy
Date:Aug 17, 2016 - Aug 17, 2017
Return:+81.60%
The most profitable trade made by John Henneman
See the Latest Stocks Traded by Insiders

John Henneman's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ANIK
Anika Therapeutics
Jun 23, 2026
Director
Uninformative Buy
―
$1.36M
OFIX
Orthofix Medical
Jun 12, 2026
Director
Uninformative Buy
―
$982.64K
LUMO
Lumos Pharma
Oct 02, 2018
―
Uninformative Sell
5.66K
$238.93K
RCM
R1 RCM
Nov 19, 2024
―
Uninformative Sell
1.26M
$0.00
APRE
Aprea Therapeutics
Jun 17, 2026
Director
Uninformative Buy
―
$10.61K
SPNE
SeaSpine Holdings
Jan 09, 2023
―
Uninformative Sell
―
$0.00
IART
Integra Lifesciences
Aug 26, 2014
CorpVP, CAO
Informative Sell
1.00M
$571.14K
List of latest transactions for each holding click on a transaction to see John Henneman's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

John Henneman insider profile FAQ

What is the percentage of profitable transactions made by John Henneman?
The percentage of profitable transactions made by John Henneman is 55%.
    What is the average return per transaction made by John Henneman?
    The average return per transaction made by John Henneman is -2.10%.
      What stocks does John Henneman hold?
      John Henneman holds: ANIK, OFIX, LUMO, RCM, APRE, SPNE, IART stocks.
        What was John Henneman’s latest transaction?
        John Henneman latest transaction was an Uninformative Buy of ―.
          What was John Henneman's most profitable transaction?
          John Henneman’s most profitable transaction was an Informative Buy of RCM stock on August 17, 2016. The return on the trade was 81.60%.
            What is John Henneman's role in Anika Therapeutics?
            John Henneman's role in Anika Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.